Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Chemistry & Biology
|
July 28, 1999
Paradoxical activation of Raf by a novel Raf inhibitor
C A Hall-Jackson, P A Eyers, P Cohen, et al.
The British Journal of Ophthalmology
|
May 9, 2015
Prevalence and risk factors of epiretinal membrane in a cohort with cardiovascular disease risk, compared with the Blue Mountains Eye Study
Sarah B Wang, Paul Mitchell, Adam J H Plant, et al.
Biochemistry
|
May 4, 2005
Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes
Jiandong Zhang, Timothy D Osslund, Matthew H Plant, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 9, 2007
New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation
Mike Frohn, Han Xu, Xiaoming Zou, et al.
Journal of Human Hypertension
|
May 13, 2016
Hypertension is associated with narrower retinal arteriolar calibre in persons with and without coronary artery disease
S B Wang, P Mitchell, A J H Plant, et al.
Journal of Thoracic Disease
|
September 14, 2016
Chronic kidney disease and the severity of coronary artery disease and retinal microvasculature changes: a cross-sectional study
Kevin Phan, Cheryl Au, Paul Mitchell, et al.
Microcirculation (New York, N.Y. : 1994)
|
February 14, 2019
Retinal microvascular changes in microvascular angina: Findings from the Australian Heart Eye Study
Gerald Liew, Paul Mitchell, Joseph Chiha, et al.
Magma (New York, N.Y.)
|
January 5, 2002
Progress in high field MRI at the University of Florida
B Beck, D H Plant, S C Grant, et al.
European Journal of Medicinal Chemistry
|
June 3, 2017
Applications of parallel synthetic lead hopping and pharmacophore-based virtual screening in the discovery of efficient glycine receptor potentiators
Nagasree Chakka, Kristin L Andrews, Loren M Berry, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2006
Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents
Roland W Bürli, Han Xu, Xiaoming Zou, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Chemistry & Biology
|
July 28, 1999
Paradoxical activation of Raf by a novel Raf inhibitor
C A Hall-Jackson, P A Eyers, P Cohen, et al.
The British Journal of Ophthalmology
|
May 9, 2015
Prevalence and risk factors of epiretinal membrane in a cohort with cardiovascular disease risk, compared with the Blue Mountains Eye Study
Sarah B Wang, Paul Mitchell, Adam J H Plant, et al.
Biochemistry
|
May 4, 2005
Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes
Jiandong Zhang, Timothy D Osslund, Matthew H Plant, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 9, 2007
New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation
Mike Frohn, Han Xu, Xiaoming Zou, et al.
Journal of Human Hypertension
|
May 13, 2016
Hypertension is associated with narrower retinal arteriolar calibre in persons with and without coronary artery disease
S B Wang, P Mitchell, A J H Plant, et al.
Journal of Thoracic Disease
|
September 14, 2016
Chronic kidney disease and the severity of coronary artery disease and retinal microvasculature changes: a cross-sectional study
Kevin Phan, Cheryl Au, Paul Mitchell, et al.
Microcirculation (New York, N.Y. : 1994)
|
February 14, 2019
Retinal microvascular changes in microvascular angina: Findings from the Australian Heart Eye Study
Gerald Liew, Paul Mitchell, Joseph Chiha, et al.
Magma (New York, N.Y.)
|
January 5, 2002
Progress in high field MRI at the University of Florida
B Beck, D H Plant, S C Grant, et al.
European Journal of Medicinal Chemistry
|
June 3, 2017
Applications of parallel synthetic lead hopping and pharmacophore-based virtual screening in the discovery of efficient glycine receptor potentiators
Nagasree Chakka, Kristin L Andrews, Loren M Berry, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2006
Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents
Roland W Bürli, Han Xu, Xiaoming Zou, et al.
Page
of 4